- Home
- CUE vs SELF Comparison
CUE vs SELF Comparison
Compare CUE & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- SELF
- Stock Information
- Founded
- CUE 2014
- SELF 1983
- Country
- CUE United States
- SELF United States
- Employees
- CUE N/A
- SELF N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- SELF Real Estate Investment Trusts
- Sector
- CUE Health Care
- SELF Real Estate
- Exchange
- CUE Nasdaq
- SELF Nasdaq
- Market Cap
- CUE 48.0M
- SELF 56.9M
- IPO Year
- CUE 2018
- SELF N/A
- Fundamental
- Price
- CUE $0.70
- SELF $5.53
- Analyst Decision
- CUE Strong Buy
- SELF
- Analyst Count
- CUE 3
- SELF 0
- Target Price
- CUE $3.00
- SELF N/A
- AVG Volume (30 Days)
- CUE 220.4K
- SELF 24.4K
- Earning Date
- CUE 08-13-2025
- SELF 08-08-2025
- Dividend Yield
- CUE N/A
- SELF 5.27%
- EPS Growth
- CUE N/A
- SELF 15.74
- EPS
- CUE N/A
- SELF 0.22
- Revenue
- CUE $7,991,000.00
- SELF $12,622,544.00
- Revenue This Year
- CUE N/A
- SELF N/A
- Revenue Next Year
- CUE $23.84
- SELF N/A
- P/E Ratio
- CUE N/A
- SELF $25.11
- Revenue Growth
- CUE 13.83
- SELF 3.58
- 52 Week Low
- CUE $0.45
- SELF $4.60
- 52 Week High
- CUE $1.99
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- CUE 55.84
- SELF 49.10
- Support Level
- CUE $0.54
- SELF $5.61
- Resistance Level
- CUE $0.66
- SELF $5.81
- Average True Range (ATR)
- CUE 0.06
- SELF 0.13
- MACD
- CUE 0.01
- SELF -0.04
- Stochastic Oscillator
- CUE 81.98
- SELF 6.45
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.